K. NörredamT. ChainuvatiP. GimsingE. HippeV. ViranuvattiMahidol UniversityAmtssygehuset i GentofteKobenhavns Amtssygehus2018-10-122018-10-121983-01-01Scandinavian Journal of Gastroenterology. Vol.18, No.2 (1983), 229-232003655212-s2.0-0020661135https://repository.li.mahidol.ac.th/handle/123456789/30539Of 37 patients with histologically verified hepatocellular carcinoma (HCC) from Bangkok, Thailand, 34 had raised values of plasma cobalamin, and 1 presented with a markedly increased value of plasma transcobalamin I (TC I). One patient with clinical malignancy of the liver, not proven histologically to be HCC, had a raised plasma cobalamin value and a markedly increased value of TC I. From our own studies and from studies in the literature we find circumstantial evidence that TC I occasionally is produced by the malignant liver cells in HCC. © 1983 Informa UK Ltd.Mahidol UniversityMedicinePlasma cobalamin and transcobalamin in patients with primary carcinoma of the liver: A study from ThailandArticleSCOPUS10.3109/00365528309181588